Subjective Reasons for Non-Reporting of Adverse Drug Reactions in a Sample of Physicians in Outpatient Care

被引:17
|
作者
Gahr, M. [1 ]
Eller, J. [1 ]
Connemann, B. J. [1 ]
Schoenfeldt-Lecuona, C. [1 ]
机构
[1] Univ Ulm, Dept Psychiat & Psychotherapy 3, Leimgrubenweg, Ulm, Germany
关键词
drug safety surveillance; pharmacovigilance; survey; underreporting; HEALTH-PROFESSIONALS; PHARMACOVIGILANCE; KNOWLEDGE; ATTITUDES; INTERVENTIONS; FREQUENCY; EVENTS; REGION; EUROPE; SYSTEM;
D O I
10.1055/s-0035-1569291
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Drug safety surveillance strongly depends on the spontaneous reporting of adverse drug reactions (ADRs). A major limiting factor of spontaneous reporting systems is underreporting (UR) which describes incorrectly low reporting rates of ADRs. Factors contributing to UR are numerous and feature country-dependent differences. Understanding causes of and factors associated with UR is necessary to facilitate targeted interventions to improve ADR reporting and pharmacovigilance. Methods: A cross-sectional questionnaire-based telephone survey was performed among physicians in outpatient care in a federal state of Germany. Results: From n=316 eligible physicians n=176 completed the questionnaire (response rate=55.7%). Most of the physicians (n=137/77.8%) stated that they report ADRs which they have observed to the competent authority rarely (n=59/33.5%), very rarely (n=59/33.5%) or never (n=19/10.8%); the majority (n=123/69.9%) had not reported any ADRs in 2014. Frequent subjective reasons for non-reporting of ADR were (specified response options): lack of time (n=52/29.5%), the subjective evaluation that the required process of reporting is complicated (n=47/26.7%) or requires too much time (n=25/14.2%) or the assessment that reporting of an ADR is needless (n=22/12.5%); within open answers the participants frequently stated that they do not report ADRs that are already known (n=72/40.9%) and they only report severe ADRs (n=46/26.1%). Discussion: Our results suggest a need to inform physicians about pharmacovigilance and to modify the required procedure of ADR reporting or to offer other reporting options.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 50 条
  • [1] Adverse drug reactions reporting by physicians in Ibadan, Nigeria
    Okezie, Enwere O.
    Fawole, Olufunmilayo, I
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (05) : 517 - 522
  • [2] Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists
    Lemay, Jacinthe
    Alsaleh, Fatemah M.
    Al-Buresli, Lulwa
    Al-Mutairi, Mohammed
    Abahussain, Eman A.
    Bayoud, Tania
    MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (01) : 30 - 38
  • [3] Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden
    Ekman, Elisabet
    Backstrom, M.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (01) : 43 - 46
  • [4] Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden
    Elisabet Ekman
    M. Bäckström
    European Journal of Clinical Pharmacology, 2009, 65 : 43 - 46
  • [5] Adverse drug reactions (ADRS) reporting: awareness and reasons of under-reporting among health care professionals, a challenge for pharmacists
    Shamim, Sumbul
    Sharib, Syed Muhammad
    Malhi, Saima Mahmood
    Muntaha, Sidrat-ul
    Raza, Hassan
    Ata, Saniya
    Farooq, Ali Salman
    Hussain, Mehwish
    SPRINGERPLUS, 2016, 5
  • [6] Reasons for reporting adverse drug reactions - Some thoughts based on an international review
    Biriell, C
    Edwards, IR
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1997, 6 (01) : 21 - 26
  • [7] LGBTQ plus Hate Crimes: Understanding Victim Reasons for Non-Reporting
    Jachimowski, Kayla G.
    Pinskey, Carley
    Donate, Gianna
    CRIME & DELINQUENCY, 2024, 70 (13-14) : 3688 - 3708
  • [8] Reporting of adverse drug reactions
    Soletsky, LM
    POSTGRADUATE MEDICINE, 1997, 102 (01) : 35 - 36
  • [9] Reporting Adverse Drug Reactions
    Wooten, James
    SOUTHERN MEDICAL JOURNAL, 2009, 102 (04) : 345 - 346
  • [10] REPORTING OF ADVERSE DRUG REACTIONS
    GOLDMAN, P
    NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (11): : 584 - 584